Fluvoxamine may prevent clinical deterioration in mild symptomatic COVID-19 compared with placebo Dec. 11, 2020
Activity profiling and crystal structures to guide the design of SARS-CoV-2 PLpro inhibitors Dec. 10, 2020
Topline data from phase III DARE-BVFREE study of DARE-BV1 in women with bacterial vaginosis Dec. 9, 2020
RSS